KalVista Pharmaceuticals Shares Response Drivers in Sebetralstat Placebo-controlled Clinical Trials
Analysis shows sebetralstat 600 mg achieved symptom relief sooner than placebo, regardless of time to treatment, attack location, or severity
International Experts Reach Consensus on Epinephrine Use for Allergic Reactions
Panel provides guidance on when to administer epinephrine and activate emergency services for varying symptom severity
Discovery Could Make Immune Checkpoint Inhibitors Safer
Experts report proof-of-concept results that may reduce risk of lethal side effect from cancer immunotherapies.